Naringin can enhance the absorption of colchicine (Dahan and Amidon, 2009), strengthen the lipid-lowering effect of Atorvastatin (Sama et al., 2019), increase the uptake of cisplatin (Mei-ying et al., 2019) and paclitaxel by cancer cells (Choi and Shin, 2005), and reduce the efflux of anti-tumor drugs by regulating P-gp; It is suggested that Naringin can improve the biological activity of drugs and can be used as a drug enhancer. The gene discussed is PGP; the disease is cancer.